NCT06911801View on ClinicalTrials.gov

In Vitro Study of [18F]F-FAPI-74 Feasibility in Vulvar Cancer

Not yet recruitingOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

April 30, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

November 30, 2026

Conditions
Vulvar Squamous Cell Carcinoma
Trial Locations (1)

00168

Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome

All Listed Sponsors
lead

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

OTHER

NCT06911801 - In Vitro Study of [18F]F-FAPI-74 Feasibility in Vulvar Cancer | Biotech Hunter | Biotech Hunter